Our extensive experience in health technology assessment (HTA) through providing strategic advice and guiding evidence generation to support submissions to UK HTA bodies, enables us to provide you with a tailored solution to reimbursement and patient access.
A systematic approach to understanding challenges in the health technology assessment of rare diseases. Presented at: WODC Europe 2025; 28-29 October 2025; Amsterdam, Netherlands.